Table 4.
Drug | Protein | Cell line | Method | Induction effect |
---|---|---|---|---|
ADM | P-gp, MRP1, BCRP | MCF-7 | RT-PCR | Louisa et al7 proved that after pretreatment with doxorubicin, the expression of P-gp, MRP1, and BCRP in MCF-7 increased significantly. |
P-gp and MRP1 | HepG-2 | Western blot | Ye et al14 incubated HepG-2 for 24 hours with ADM and found that the expression of P-gp and MRP1 was significantly increased. | |
P-gp | SMMC-7721 | Flow cytometry | Yan et al15 measured protein expression level with flow cytometry and pointed out that in SMMC-7721/ADM, P-gp expression increased. | |
MX | P-gp and MRP1 | MCF-7 | Western blot | Morrow et al9 found that P-gp and MRP1 were both increased in MCF-7/MX. |
BCRP | MCF-7 | Western blot | Greijer et al13 induced MCF-7 with MX and WB results showed that the expression of BCRP increased. | |
BCRP | HepG-2 | RT-PCR, Western blot, flow cytometry | Ren et al12 measured high BCRP expression in HepG-2/MX. | |
P-gp | PBMCs | RT-PCR, flow cytometry | Yao et al17 proved that the expression of P-gp in the resistant cells was higher. | |
MTX | MRP1 | MCF-7 | Western blot | Volk et al16 showed that MRP1 expression increased when MCF-7 was induced by MTX. |
BCRP | HL-60 | Flow cytometry | Hilovska et al11 proved that BCRP was overexpressed in resistant cells. |
Abbreviations: P-gp, permeability glycoprotein; MRP1, multidrug resistance-related protein 1; BCRP, breast cancer resistance proteins; ADM, adriamycin; MX, mitoxantrone; MTX, methotrexate; PBMCs, peripheral blood mononuclear cells; RT-PCR, real-time polymerase chain reaction; WB, Western blot.